The AI-Augmented Career: How Respiratory Therapists Can Leverage Technology to Advance Their Professional Journey on September 12, 2026 Posted by
A House Divided: The Growing Institutional Crisis Within the American Diabetes Association on September 12, 2026 Posted by
The Power of Small Steps: How Tiny Lifestyle Tweaks Can Transform Your Heart Health on September 12, 2026 Posted by
The Future of Rest: HoneyNaps Transforms Sleep Diagnostics with Wireless AI-Powered PSG on September 12, 2026 Posted by
Seeking a Champion for Healthy Aging: Alliance for Aging Research Announces Search for New Policy Director on September 12, 2026 Posted by
Vietnam vs. Malaysia: A Tactical Breakdown and Strategic Preview for the Upcoming Clash on September 12, 2026 Posted by
The AI-Augmented Career: How Respiratory Therapists Can Leverage Technology to Advance Their Professional Journey on September 12, 2026 Posted by
A House Divided: The Growing Institutional Crisis Within the American Diabetes Association on September 12, 2026 Posted by
The Power of Small Steps: How Tiny Lifestyle Tweaks Can Transform Your Heart Health on September 12, 2026 Posted by
Posted in Sleep Health A New Frontier in Sleep Medicine: Promising Phase 2 Results for Alixorexton in Narcolepsy Type 1 on September 4, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: The Potential of Alixorexton on August 27, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Extension Study on August 10, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Medical Innovations The Orexin Frontier: How Alkermes Is Positioning Its "Alixorexton" to Disrupt the Sleep Medicine Landscape on June 27, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
